scholarly article | Q13442814 |
P50 | author | Heyu Ni | Q42158077 |
Andrew R. Crow | Q42723674 | ||
Alan H Lazarus | Q56506370 | ||
Edwin H Kim | Q89605246 | ||
John Freedman | Q106606557 | ||
Edwin R Speck | Q106606600 | ||
Rukhsana Aslam | Q117255419 | ||
K W Annie Bang | Q117255420 | ||
John W. Semple | Q6262535 | ||
P2093 | author name string | Frederick P Nestel | |
P2860 | cites work | Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene | Q22299417 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | toll-like receptor | Q408004 |
lipopolysaccharide | Q421804 | ||
thrombocytopenia | Q585285 | ||
P304 | page(s) | 637-641 | |
P577 | publication date | 2005-09-22 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo | |
P478 | volume | 107 |
Q33267507 | A comprehensive proteomics and genomics analysis reveals novel transmembrane proteins in human platelets and mouse megakaryocytes including G6b-B, a novel immunoreceptor tyrosine-based inhibitory motif protein |
Q35060782 | A novel conditional platelet depletion mouse model reveals the importance of platelets in protection against Staphylococcus aureus bacteremia. |
Q33435590 | Advances in the pathophysiology of primary immune thrombocytopenia |
Q34491825 | Aggregation and microparticle production through toll-like receptor 4 activation in platelets from recently menopausal women |
Q37250787 | Amicus or adversary: platelets in lung biology, acute injury, and inflammation |
Q28083403 | Are Platelets Cells? And if Yes, are They Immune Cells? |
Q38390385 | Bacteria-induced intracellular signalling in platelets |
Q38287964 | Bacterial and Viral Products Affect Differential Pattern Recognition Receptor Activation of Chicken Thrombocytes Evidenced through RNA Sequencing. |
Q50083068 | Bacterial endotoxin as inhibitor of the enzymatic activity of human thrombin. |
Q37704366 | Bacterial-platelet interactions: virulence meets host defense |
Q38133641 | Bench-to-bedside review: Platelets and active immune functions - new clues for immunopathology? |
Q33401507 | Bidirectional crosstalk between platelets and monocytes initiated by Toll-like receptor: an important step in the early defense against fungal infections? |
Q45059688 | Blood platelets and biological response to 'danger' signals and subsequent inflammation: towards a new paradigm? |
Q34204639 | Calpain activity and Toll-like receptor 4 expression in platelet regulate haemostatic situation in patients undergoing cardiac surgery and coagulation in mice. |
Q37558436 | Cancer and Thrombosis: The Platelet Perspective. |
Q33441156 | Celiac Disease Presenting with Immune Thrombocytopenic Purpura |
Q38893859 | Cell-based detection of microbial biomaterial contaminations |
Q35607298 | Cellular fibronectin containing extra domain A promotes arterial thrombosis in mice through platelet Toll-like receptor 4 |
Q33409710 | Cellular immune dysfunction in immune thrombocytopenia (ITP). |
Q35156132 | Characterization of Toll-like receptor-4 (TLR-4) in the spleen and thymus of Swiss albino mice and its modulation in experimental endotoxemia |
Q58714196 | Circulating H3Cit is elevated in a human model of endotoxemia and can be detected bound to microvesicles |
Q30415074 | Clopidogrel treatment and the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of antiplatelet therapy in pneumonia and critical illness |
Q42677153 | Coronary heart disease risk factors take a disproportional toll on women |
Q33403517 | Crosstalk between Platelets and the Immune System: Old Systems with New Discoveries |
Q55170613 | Dendrobium Officinale Kimura et Migo Ameliorates Insulin Resistance in Rats with Diabetic Nephropathy. |
Q64099633 | Dengue virus nonstructural protein 1 activates platelets via Toll-like receptor 4, leading to thrombocytopenia and hemorrhage |
Q28390993 | Down-regulation of platelet surface CD47 expression in Escherichia coli O157:H7 infection-induced thrombocytopenia |
Q62776798 | Dual actions of group B Streptococcus capsular sialic acid provide resistance to platelet-mediated antimicrobial killing |
Q91657132 | Effect of ultrapure lipopolysaccharides derived from diverse bacterial species on the modulation of platelet activation |
Q54211951 | Emerging Concepts in Immune Thrombocytopenia. |
Q38310270 | Emerging evidence for platelets as immune and inflammatory effector cells |
Q27016553 | Emerging roles for platelets as immune and inflammatory cells |
Q33391838 | Endotoxaemia in the pathogenesis of cytopenias in liver cirrhosis. Could oral antibiotics raise blood counts? |
Q36510868 | Engagement of platelet toll-like receptor 9 by novel endogenous ligands promotes platelet hyperreactivity and thrombosis. |
Q35895151 | Expression and Polymorphism of Toll-Like Receptor 4 and Effect on NF-κB Mediated Inflammation in Colon Cancer Patients |
Q51704486 | Expression and function of IL-1R8 (TIR8/SIGIRR): a regulatory member of the IL-1 receptor family in platelets. |
Q47727224 | Expression of CD markers' in immune thrombocytopenic purpura: prognostic approaches. |
Q35172492 | Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4 |
Q57416706 | Genetic polymorphisms in the endotoxin receptor may influence platelet count as part of the acute phase response in critically ill children |
Q47372701 | Granzyme A in Human Platelets Regulates the Synthesis of Proinflammatory Cytokines by Monocytes in Aging. |
Q39347876 | Hematoma-inspired alginate/platelet releasate/CaPO4 composite: initiation of the inflammatory-mediated response associated with fracture repair in vitro and ex vivo injection delivery |
Q57027381 | Human blood platelets and viruses: defense mechanism and role in the removal of viral pathogens |
Q42366210 | Human platelet interaction with E. coli O111 promotes tissue-factor-dependent procoagulant activity, involving Toll like receptor 4. |
Q56978745 | Immuno-compatibility of amphiphilic ABA triblock copolymer-based hydrogel films for biomedical applications |
Q33427877 | Improvement of prognostic performance in severely injured patients by integrated clinico-transcriptomics: a translational approach |
Q33379066 | Increased risk of immune thrombocytopenic purpura among inpatients with coeliac disease |
Q37351096 | Induction of thymic stromal lymphopoietin production by nonanoic acid and exacerbation of allergic inflammation in mice. |
Q90401101 | Inflammation Induced by Platelet-Activating Viperid Snake Venoms: Perspectives on Thromboinflammation |
Q33864069 | Inflammation and thrombosis in cardiovascular disease. |
Q27692695 | Inflection points in sepsis biology: from local defense to systemic organ injury |
Q38647663 | Influenza virus non‑structural protein 1 inhibits the production of interferon β of alveolar epithelial cells upon the infection of influenza A H1N1. |
Q40896463 | Inhibition of COX-1 attenuates the formation of thromboxane A2 and ameliorates the acute decrease in glomerular filtration rate in endotoxemic mice. |
Q55037178 | Investigation of celiac disease followed by immune thrombocytopenic purpura diagnosis in patients and comparison with literature. |
Q24306498 | Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome |
Q42248441 | Lipopolysaccharide is a direct agonist for platelet RNA splicing |
Q35001472 | Lipopolysaccharide signaling without a nucleus: kinase cascades stimulate platelet shedding of proinflammatory IL-1β-rich microparticles |
Q33384817 | Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway |
Q37281999 | Lipopolysaccharide stimulates platelets through an IL-1β autocrine loop |
Q33391926 | Long term changes in platelet counts after H. pylori eradication in non-ITP patients |
Q92543091 | Macrophage Depletion Mitigates Platelet Aggregate Formation in Splenic Marginal Zone and Alleviates LPS-Associated Thrombocytopenia in Rats |
Q37765801 | Mechanisms of oral bacteria-induced platelet activation. |
Q43135345 | Mechanisms underlying the inhibitory effects of lipopolysaccharide on human platelet adhesion |
Q29994808 | Microfluidic system for monitoring temporal variations of hemorheological properties and platelet adhesion in LPS-injected rats |
Q37625592 | NF-κB Links TLR2 and PAR1 to Soluble Immunomodulator Factor Secretion in Human Platelets |
Q39147112 | New Concepts and Mechanisms of Platelet Activation Signaling |
Q37233599 | New strategy for sepsis: Targeting a key role of platelet-neutrophil interaction |
Q42382293 | Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance |
Q35246390 | Nucleotide-binding oligomerization domain 2 receptor is expressed in platelets and enhances platelet activation and thrombosis |
Q33439412 | Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP) |
Q92603378 | Patrolling the vascular borders: platelets in immunity to infection and cancer |
Q33376821 | Picogram doses of lipopolysaccharide exacerbate antibody-mediated thrombocytopenia and reduce the therapeutic efficacy of intravenous immunoglobulin in mice |
Q91971794 | Platelet Inflammatory Response to Stress |
Q28294906 | Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood |
Q48133269 | Platelet activation and aggregation by the opportunistic pathogen Cutibacterium (Propionibacterium) acnes |
Q40897514 | Platelet activation suppresses HIV-1 infection of T cells |
Q38073155 | Platelet biology and receptor pathways. |
Q43706324 | Platelet immunology and the immune response |
Q38390429 | Platelet interaction with bacterial toxins and secreted products |
Q41300060 | Platelet leukocyte aggregates and markers of platelet aggregation, immune activation and disease progression in HIV infected treatment naive asymptomatic individuals |
Q34298384 | Platelet response as a sentinel marker of toll-like receptor 4 activation in mice |
Q38362628 | Platelet transfusion - the new immunology of an old therapy |
Q37678953 | Platelet-bacterial interactions. |
Q36508925 | Platelet-derived CD154 enables T-cell priming and protection against Listeria monocytogenes challenge |
Q36335907 | Platelet-derived HMGB1 is a critical mediator of thrombosis. |
Q34387761 | Platelet-derived Toll-like receptor 4 (Tlr-4) is sufficient to promote microvascular thrombosis in endotoxemia. |
Q89143066 | Platelets Enhance Dendritic Cell Responses against Staphylococcus aureus through CD40-CD40L |
Q55279252 | Platelets Promote Brucella abortus Monocyte Invasion by Establishing Complexes With Monocytes. |
Q47381141 | Platelets Toll-like receptor-4 in Crohns disease |
Q38017397 | Platelets and cytokines: How and why? |
Q33440142 | Platelets and infections in the resource-limited countries with a focus on malaria and viral haemorrhagic fevers |
Q37657202 | Platelets and innate immunity |
Q37857647 | Platelets and the immune continuum |
Q33432917 | Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond |
Q37809184 | Platelets as Central Mediators of Systemic Inflammatory Responses |
Q37081746 | Platelets as cellular effectors of inflammation in vascular diseases |
Q38160535 | Platelets as immune cells in infectious diseases. |
Q34590168 | Platelets as immune mediators: Their role in host defense responses and sepsis |
Q57676581 | Platelets as immune-sensing cells |
Q33427709 | Platelets attenuate production of cytokines and nitric oxide by macrophages in response to bacterial endotoxin |
Q55004062 | Platelets in Immune Response to Virus and Immunopathology of Viral Infections. |
Q26739670 | Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases |
Q92405179 | Platelets in Sepsis: An Update on Experimental Models and Clinical Data |
Q33604443 | Platelets in defense against bacterial pathogens |
Q39027765 | Platelets in infectious disease. |
Q38039852 | Platelets in inflammation and immune modulations: functions beyond hemostasis |
Q38364980 | Platelets in leucocyte recruitment and function |
Q39001947 | Platelets in neutrophil recruitment to sites of inflammation |
Q36237204 | Platelets in the pathogenesis of acute respiratory distress syndrome |
Q38944864 | Platelets promote tumour metastasis via interaction between TLR4 and tumour cell-released high-mobility group box1 protein |
Q33411077 | Platelets protect from septic shock by inhibiting macrophage-dependent inflammation via the cyclooxygenase 1 signalling pathway |
Q57653563 | Platelets regulate leucocyte responses to Toll-like receptor stimulation |
Q38032475 | Platelets: active players in the pathogenesis of arthritis and SLE. |
Q38211899 | Platelets: at the nexus of antimicrobial defence |
Q92063054 | Platelets: emerging facilitators of cellular crosstalk in rheumatoid arthritis |
Q37395743 | Platelets: essential components of the immune system |
Q35101184 | Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum |
Q37820880 | Platelets: versatile modifiers of innate and adaptive immune responses to transplants |
Q33414235 | Prediction of spontaneous bacterial peritonitis in cirrhotic ascites by a simple scoring system |
Q33419547 | Properties of soluble glycoprotein VI, a potential platelet activation biomarker |
Q94270413 | Protective effects of saponins in a rat model of severe acute pancreatitis occur through regulation of inflammatory pathway signaling by upregulation of miR-181b |
Q33424810 | Qian Five Rhinoceros Gindeng (QFRG) protects against development of immune thrombocytopenia via miR-181a inhibition of TLR-4 expression |
Q42517118 | RBCs Homeostatically Bind mtDNA Through TLR9 to Maintain Quiescence and Prevent Lung Injury |
Q35037420 | Regulatory effects of TLR2 on megakaryocytic cell function |
Q37869814 | Review of cellular and molecular pathways linking thrombosis and innate immune system during sepsis. |
Q33398338 | Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia |
Q59791517 | Role of Platelets in Leukocyte Recruitment and Resolution of Inflammation |
Q35258847 | Role of Siglec-7 in apoptosis in human platelets |
Q55242898 | Role of matrix metalloproteinases 2 and 9, toll-like receptor 4 and platelet-leukocyte aggregate formation in sepsis-associated thrombocytopenia. |
Q33894675 | Sepsis prediction in critically ill patients by platelet activation markers on ICU admission: a prospective pilot study |
Q42137745 | Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase |
Q30528922 | T granules in human platelets function in TLR9 organization and signaling |
Q90314951 | TLR4-dependent upregulation of the platelet NLRP3 inflammasome promotes platelet aggregation in a murine model of hindlimb ischemia |
Q36140535 | The Dynamics of Platelet Activation during the Progression of Streptococcal Sepsis |
Q90401541 | The Era of Thromboinflammation: Platelets Are Dynamic Sensors and Effector Cells During Infectious Diseases |
Q27004467 | The Inflammatory Role of Platelets via Their TLRs and Siglec Receptors |
Q93092336 | The Role of Human Platelet Preparation for Toll-Like Receptors 2 and 4 Related Platelet Responsiveness |
Q52725381 | The non-haemostatic role of platelets in systemic lupus erythematosus. |
Q33413094 | The role of calpain-myosin 9-Rab7b pathway in mediating the expression of Toll-like receptor 4 in platelets: a novel mechanism involved in α-granules trafficking |
Q37640684 | The role of inflammation in regulating platelet production and function: Toll-like receptors in platelets and megakaryocytes |
Q33424454 | The role of platelet MyD88 in host response during gram-negative sepsis. |
Q88671029 | The role of platelets in acute kidney injury |
Q35186543 | The role of platelets in the pathogenesis of viral hemorrhagic fevers |
Q34277327 | The role of whole blood impedance aggregometry and its utilisation in the diagnosis and prognosis of patients with systemic inflammatory response syndrome and sepsis in acute critical illness |
Q34765561 | The septic milieu triggers expression of spliced tissue factor mRNA in human platelets. |
Q57476223 | Thrombocytopenia Impairs Host Defense Against Burkholderia pseudomallei (Melioidosis) |
Q33418094 | Thrombocytopenia impairs host defense in gram-negative pneumonia-derived sepsis in mice |
Q33423030 | Thrombocytopenia in Dengue: Interrelationship between Virus and the Imbalance between Coagulation and Fibrinolysis and Inflammatory Mediators |
Q34316343 | Thrombosis as an intravascular effector of innate immunity |
Q47147432 | Toll-Like Receptor 4 Signalling and Its Impact on Platelet Function, Thrombosis, and Haemostasis. |
Q98166177 | Toll-Like Receptor 9 (TLR9) Gene C/T (rs352140) Polymorphisms in Adult Primary Immune Thrombocytopenia |
Q36038084 | Toll-Like Receptor Signalling Is Not Involved in Platelet Response to Streptococcus pneumoniae In Vitro or In Vivo |
Q34734986 | Toll-like receptor 4 regulates platelet function and contributes to coagulation abnormality and organ injury in hemorrhagic shock and resuscitation |
Q53687316 | Toll-like receptors in immunity and inflammatory diseases: Past, present, and future. |
Q37283036 | Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome |
Q36155410 | Transcriptome Profile of the Chicken Thrombocyte: New Implications as an Advanced Immune Effector Cell |
Q50115928 | Translational Implications of Platelets as Vascular First Responders |
Q64066933 | Understanding Platelets in Infectious and Allergic Lung Diseases |
Q36928258 | Whole blood impedance aggregometry as a biomarker for the diagnosis and prognosis of severe sepsis |
Q83630769 | [In vitro platelet production] |
Q82239801 | [Platelets "Toll-like receptor" engagement stimulates the release of immunomodulating molecules] |
Q43072124 | beta-glucan from Saccharomyces cerevisiae as a blood platelet antioxidant |
Q91785228 | miR‑148 family members are putative biomarkers for sepsis |
Search more.